Psilocybin vs escitalopram for depression, recent trial findings

Listen to the episode

Description

In this episode:

  • A recent study Prof David Nutt was involved in pitted psilocybin against escitalopram in a cleverly designed equipoise randomised controlled trial
  • Results showed very rapid improvement (days rather than weeks) of depression symptoms and significantly better scores in wellbeing and depression in patients given psilocybin
  • Whilst it is clear more studies are needed, there is growing interest in the use of psychedelic agents in the treatment of depression amongst younger and trainee psychiatrists, psychotherapists, and the general public
  • As GPs, we should be aware of developments in this area

 

Host: Dr David Lim, GP and Medical Educator

Total time: 32 mins

Guest: Prof David Nutt, Neuropsychopharmacologist

 

Last Updated: 16 Nov, 2021

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Shannon Thomas

Dr Shannon Thomas

TIAs and Carotid Stenosis

Dr Ginni Mansberg

Dr Ginni Mansberg

Low libido - What is it & How is it Managed?

Dr Rupert Hinds

Dr Rupert Hinds

Functional Gastrointestinal Disorders in Infants – Practical Advice for HCPs

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM

Using the New RSV Vaccine in Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof David Nutt

expert

Prof David Nutt

Neuropsychopharmacologist; Director of the Neuropsychopharmacology Unit; Division of Brain Sciences; Imperial College, London

Recent articles

Share this

You have completed the Educational Activities component of this resource. 

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.